Propanc Biopharma Advances Bioanalytical & Immunogenicity Assay Development for Phase 1b First-In-Human Study in up to 50 Advanced Cancer Patients
"By undertaking these important bioanalytical activities, we are going to obtain great insight into the effects of PPC-001”
Covered in this story
Call it yourself
No calls on $PPC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Pilgrim's Pride →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.